Adastra Holdings Ltd.
Adastra Holdings Ltd.
Founded in 2014, Adastra Holdings Ltd. through its Health Canada licensed subsidiary, Adastra Labs has built a successful reputation as a leading cannabis processor. Adastra manufactures products for its successful in-house concentrates brands Phyto Extractions and Endgame Extracts and co-manufactures for many Canadian cannabis brands. With products sold at more than 2,000 retailers across the country.
Operating out of its 13,500 sq. ft. Health Canada Licensed Standard Processing and co-located analytical testing lab facility, Adastra produces and distributes cannabis-derived products designed for medical cannabis and forward-looking therapeutic use.
Adastra received its controlled substances dealer's license in August 2022 with an amendment in February 2023 and is licensed to partner with healthcare professionals and practitioners within the regulated environment to help create efficacious remedies that address the actual needs of patients.
Adastra Holdings Ltd. (XTRX)
SEDAR Information
Information d'entreprise
Capitalisation
Communiqués de presse
Bulletins
2024-1011 – Consolidation - Adastra Holdings Ltd. (XTRX)
le 11 octobre/October 2024
Adastra Holdings Ltd. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares.
As a result, the outstanding shares of the company will be reduced to approximately 5,597,055 common shares.
The name and symbol will not change.
